glp-1 agonists and pancreatitis Frontiers Risk of pancreatitis in patients

Weigh to Go: Assessing the Wider Implications of a Slimmer Society

doi: 10.1016/j.phrs.2022.106550 24 SalcedoITweedieDLiYGreigNH

Only 5% started exercising for the first time while on GLP-1 medication, and 12% are doing so less frequently than before

Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Aldosterone-to-Renin Ratio in Diabetic Patients With Hypertension: A Retrospective Observational Study

Treatment patterns in patients with type 2 diabetes mellitus treated with glucagonlike peptide1 receptor agonists: Higher adherence and persistence with dulaglutide compared with onceweekly exenatide and liraglutide

The Foundation: Diet, Exercise, and Lifestyle Programs Before any medical intervention, lifestyle modification remains the cornerstone of health and weight management